Logo image of DMN

DAMON INC (DMN) Stock Fundamental Analysis

NASDAQ:DMN - Nasdaq - CA2357501063 - Common Stock - Currency: USD

0.242  -0.06 (-20.37%)

Premarket: 0.202 -0.04 (-16.53%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to DMN. DMN was compared to 0 industry peers in the Unkown industry. DMN has a bad profitability rating. Also its financial health evaluation is rather negative. DMN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DMN had negative earnings in the past year.
DMN had a negative operating cash flow in the past year.
DMN Yearly Net Income VS EBIT VS OCF VS FCFDMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M -1M 2M 3M 4M

1.2 Ratios

Industry RankSector Rank
ROA -108.48%
ROE N/A
ROIC N/A
ROA(3y)-41.98%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DMN Yearly ROA, ROE, ROICDMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

The Profit Margin and Operating Margin are not available for DMN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DMN Yearly Profit, Operating, Gross MarginsDMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 500 1K

More info and screens

1

2. Health

2.1 Basic Checks

DMN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DMN remains at a similar level compared to 1 year ago.
DMN has a worse debt/assets ratio than last year.
DMN Yearly Shares OutstandingDMN Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
DMN Yearly Total Debt VS Total AssetsDMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500K 1M 1.5M

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC9.65%
DMN Yearly LT Debt VS Equity VS FCFDMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500K 1M 1.5M

2.3 Liquidity

A Current Ratio of 1.01 indicates that DMN should not have too much problems paying its short term obligations.
A Quick Ratio of 1.01 indicates that DMN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1.01
DMN Yearly Current Assets VS Current LiabilitesDMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

DMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1729.01%.
DMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.11%.
EPS 1Y (TTM)-1729.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41755.56%
Revenue 1Y (TTM)-14.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.15%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DMN Yearly Revenue VS EstimatesDMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 100K 200K 300K 400K
DMN Yearly EPS VS EstimatesDMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DMN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DMN Price Earnings VS Forward Price EarningsDMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DMN Per share dataDMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DAMON INC

NASDAQ:DMN (2/25/2025, 8:00:01 PM)

Premarket: 0.202 -0.04 (-16.53%)

0.242

-0.06 (-20.37%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.34%
Inst Owner ChangeN/A
Ins Owners7.76%
Ins Owner Change1.62%
Market Cap5.33M
AnalystsN/A
Price TargetN/A
Short Float %0.57%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.84
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.02
BVpS-0.09
TBVpS-0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -108.48%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.61%
FCFM N/A
ROA(3y)-41.98%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 1.01
Altman-Z N/A
F-Score1
WACC9.65%
ROIC/WACCN/A
Cap/Depr(3y)136.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.28%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1729.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41755.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.15%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-128.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.32%
OCF growth 3YN/A
OCF growth 5YN/A